Was betrifft es? Warum ist das wichtig?

The Participant Information Sheet (PIS) is an Ethics Committee (EC) required document provided to study participants with the aim to:

 

A PIS:

  • Is site specific (i.e. the site includes its contact details for participants to reach site specific researchers, such as the Site-INV)
  • Is integrated in an informed consent process that must be described in the study protocol
  • Must be submitted and approved by EC

 

Swissethics (EC) provide PIS based on:

  • Study type (ClinO, ClinO-MD, HRO)
  • Swiss language region (German, French, Italian)
  • Type of participant (e.g. adults, children, adolescents, pregnant women, individuals without capacity to give consent)

Was muss ich befolgen?

As a SP-INV:

  • Select  from swissethics  (EC) the PIS template applicable to your study
  • Include all relevant information enabling  participants or legal representatives to decide on study participation
  • Ensure text is written in a comprehensible / lay language, easily understood by target participants
  • Submit the PIS to EC for approval. If an approved PIS is amended prior to study start, ensure the amended version is approved by EC (e.g. ensure correct document identification)

 

If a PIS must be provided in a language other than an official Swiss language, submit the translation to the EC. The EC only acknowledges the translated document. The SP-INV is responsible for the correct translation.

 

In the event of languages for which a written translation is not feasible, a qualified translator is used to inform participants. The translator confirms his/her correct translation with his/her signature.

Wo kann ich Hilfe anfordern?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

External Links

Swissethics – see in particular

  • Broad selection of Patient Information (PIS) and Informed Consent Form (ICF) templates

References

ICH GCP E6(R3) – see in particular guideline

  • Glossary: Definition informed consent
  • 2.8 Informed consent of trial participants
  • II GCP Principles Nr. 2 Informed consent is an integral part of the ethical conduct of a trial

ISO 14155:2020 Medical devices (access liable to cost) - see in particular sections

  • 5.8 Informed consent

Declaration of Helsinki – see in particular principles

  • 25 – 32 Free Informed Consent

Swiss Law

HRA – see in particular chapters

  • Art. 7 Consent
  • Art. 8 Right to receive information
  • Chapter 2, section 2 Information and Consent

ClinO – see in particular articles

  • Art. 4a Inclusion of relevant groups of persons
  • Art. 7 Information given to participants
  • Art. 8 Exemption to written form

ClinO-MD – see in particular

  • Art. 3a Inclusion of relevant groups of persons
  • Art. 3b Applicable provisions (refer to ClinO)

HRO – see in particular articles

  • Art. 2c Inclusion of relevant groups of persons
  • Art. 8 Information given to participants
  • Art. 9 Exemption to the written form
Abkürzungen
  • ClinO – Clinical Trials Ordinance
  • ClinO-MD – Ordinance on Clinical Trials with Medical Devices
  • CTU – Clinical Trials Unit
  • EC – Ethics Committee
  • GDPR - General Data Protection Regulation
  • ICH-GCP – International Council for Harmonisation - Good Clinical Practice
  • HRO – Human Research Ordinance
  • ISO – International Organization for Standardization
  • HRO – Human Research Ordinance
  • PIS – Participant Information Sheet
  • Site-INV – Site-Investigator
Development ↦ Management ↦ Study Documents ↦ Participant Information Sheet
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Development ↦ Management ↦ Study Documents ↦ Participant Information Sheet